Records containing: Psoriasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-10-26Psychotherapy for Patients With Psoriasis: Effects in Quality of Life
-
CLINICAL_TRIALS study record update · 2016-10-26T and B Cell Responses Across Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2016-10-26Quality of Life, Emotional and Sleep Problems in Chronic Skin Diseases
-
CLINICAL_TRIALS study record update · 2016-10-21A Multicenter, Randomized, Open Label, Two Treatment, Two Period, Two Sequence, Single-dose, Two-way, Crossover, Bioequivalence Study of Methotrexate Tablets USP, 2.5 mg Manufactured by Amneal Pharmaceuticals, With Methotrexate Tablets USP 2.5 mg Manufactured for DAVA Pharmaceuticals, Inc., Fort Lee, NJ 07024 USA in Patients With Mild to Severe Psoriasis or Rheumatoid Arthritis, Who Are Already on Established Regimens of 2.5 mg Every 12 Hours Under Fasting Condition.
-
CLINICAL_TRIALS study record update · 2016-10-21Early Onset of Clinical Improvement With Ixekizumab in Patients With Moderate-to-Severe Plaque Psoriasis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-10-21A 12-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients With Moderate to Severe Plaque Psoriasis With a Long-Term Extension Period
-
CLINICAL_TRIALS study record update · 2016-10-20A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2016-10-19Premature Coronary Artery Disease (CAD) in Severe Psoriasis
-
CLINICAL_TRIALS study record update · 2016-10-18A Double Blind, Randomized, Placebo-Controlled Intervention Study to Evaluate the Effectiveness and Safety of a Treatment With a Probiotic in Adult Patients Diagnosed With Mild to Moderate Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2016-10-06ClinicalTrials.gov study NCT01947491
-
CLINICAL_TRIALS study record update · 2016-09-30A Multicenter, Open-Label, Long-Term Study to Evaluate the Efficacy and Safety of LY2439821 in Japanese Patients With Moderate-to-Severe Psoriasis
-
CLINICAL_TRIALS study record update · 2016-09-21A Preliminary, Open Label, Single-arm Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy
-
CLINICAL_TRIALS study record update · 2016-09-19A 48 Weeks Study of Three Different Dose Regimens of BI 655066 Administered Subcutaneously in Patients With Moderate to Severe Chronic Plaque Psoriasis (Randomised, Dose-ranging, Active-comparator-controlled (Ustekinumab), Double-blind Within Dose Groups of BI 655066)
-
CLINICAL_TRIALS study record update · 2016-09-15An Open-label Pilot Study to Assess the Safety and Efficacy of Trichuris Suis Ova for the Treatment of Moderate to Severe Chronic Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2016-09-09Randomized Multicenter Placebo-controlled Trial on the Effect of Adalumumab on Vascular Inflammation in Patient With Moderate to Severe Psoriasis
-
CLINICAL_TRIALS study record update · 2016-08-02Ascending-Dose, Double-Blind, Placebo-Controlled, Study of Intralesional Fluphenazine Hydrochloride for Psoriasis
-
CLINICAL_TRIALS study record update · 2016-06-27Open Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Lost a Satisfactory Response to Adalimumab
-
CLINICAL_TRIALS study record update · 2016-06-21PASIMAT: Automatic Measure of PASI by Skin Imaging
-
CLINICAL_TRIALS study record update · 2016-06-16A Case Control Study to Evaluate the Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) Among Patients With Psoriasis
-
CLINICAL_TRIALS study record update · 2016-06-16A Case Control Study to Evaluate Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis.
-
CLINICAL_TRIALS study record update · 2016-06-14Evaluation of Humira Retention Rate in Psoriasis Patients in Daily Practice and Assessment of Work Productivity and Quality of Life
-
CLINICAL_TRIALS study record update · 2016-06-01Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2016-05-27A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Maintenance Dosing Period and a Long- Term Extension Period to Evaluate the Efficacy and Safety of LY2439821 in Patients With Moderate-to-Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2016-05-16Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
-
CLINICAL_TRIALS study record update · 2016-05-13Reduction of Injection-related Pain Caused by Subcutaneous Administration of Biologic Drugs in Psoriasis